ARQT Arcutis Biotherapeutics, Inc. - Common stock
$27,03
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 5, 2026
Rango 52S
$15–$32
72% of range
Calificación del Analista
BUY
14 analysts
Precio Objetivo
$37
+36% upside
P/E (TTM)
-207.9
ROE
-9.8%
Margen de Beneficio Neto
-4.3%
ARQT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$27.03
Capitalización Bursátil
$3.33B
P/E (TTM)
-207.9
BPA (TTM)
$-0.13
Ingresos (TTM)
$376M
Rendimiento div.
—
ROE
-9.8%
Deuda/Capital
0.6
Rango 52S
$15 – $32
ARQT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$376M
2020-12-31
→
2025-12-31
BPA
$-0.13
2019-12-31
→
2025-12-31
Flujo de caja libre
$-6M
2020-12-31
→
2025-12-31
Márgenes
-4.3%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ARQT
Mediana de Pares
P/E (TTM)
-207.9
—
P/S (TTM) (P/V (TTM))
8.9
18.3
P/B (P/C)
17.6
3.3
EV / EBITDA
-278.1
—
Price / FCF (Precio / FCF)
-528.2
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ARQT
Mediana de Pares
Operating Margin (Margen Operativo)
-3.2%
—
Net Profit Margin (Margen de Beneficio Neto)
-4.3%
-180.4%
ROA
-4.1%
-36.2%
ROE
-9.8%
-43.7%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ARQT
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
0.6
—
Current Ratio (Ratio corriente)
3.2
9.7
Quick Ratio (Ratio Rápido)
1.5
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ARQT
Mediana de Pares
Revenue YoY (Ingresos interanuales)
91.3%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
367.3%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ARQT
Mediana de Pares
ARQT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
14 analistas
- Compra fuerte 4 28,6%
- Compra 8 57,1%
- Mantener 2 14,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
8 analistas · 2026-08-13
Mediana
$37.00
← Por Debajo de Todos los Objetivos
$27.03
Mín
$34.00
Máx
$40.00
Objetivo mediano
$37.00
+36,9%
Objetivo medio
$36.88
+36,4%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.05%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $0.11 | $0.04 | 0.07% |
| 31 de marzo de 2026 | $-0.09 | $-0.08 | -0.01% |
| 31 de diciembre de 2025 | $0.13 | $0.12 | 0.01% |
| 30 de septiembre de 2025 | $0.06 | $-0.10 | 0.16% |
| 30 de junio de 2025 | $-0.13 | $-0.16 | 0.03% |
| 31 de marzo de 2025 | $-0.20 | $-0.21 | 0.01% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $376M | $197M | $60M | $4M | $0 | $0 | |
| Cost of Revenue | $37M | $19M | $5M | $754.0K | $0 | · | |
| R&D Expense | $77M | $76M | $111M | $182M | $146M | $115M | |
| SG&A Expense | $275M | $229M | $185M | $122M | $61M | $21M | |
| Operating Expenses | $388M | $325M | $301M | $305M | $207M | $137M | |
| Operating Income | $-12M | $-128M | $-241M | $-302M | $-207M | $-137M | |
| Interest Expense | · | · | $30M | $16M | $0 | $0 | |
| Other Non-op | $443.0K | $47.0K | $-731.0K | $6M | $173.0K | $967.0K | |
| Income Tax | $1M | $647.0K | $3M | $0 | $0 | $0 | |
| Net Income | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| EPS (Basic) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| EPS (Diluted) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| Shares (Basic) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| Shares (Diluted) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| EBITDA | $-12M | $-128M | $-241M | · | · | $-137M |
Balance general 26
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $71M | $88M | $54M | $96M | $65M | |
| Receivables | $146M | $73M | $26M | $8M | $0 | · | |
| Inventory | $23M | $15M | $13M | $8M | $0 | · | |
| Prepaid Expense | $21M | $20M | $19M | $11M | $14M | $7M | |
| Current Assets | $411M | $336M | $330M | $437M | $403M | $293M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | $532.0K | $78.0K | |
| Intangibles | $15M | $9M | $6M | $7M | $0 | · | |
| Other Non-current Assets | $1M | $596.0K | $596.0K | $78.0K | $78.0K | $78.0K | |
| Total Assets | $433M | $349M | $341M | $449M | $408M | $298M | |
| Accounts Payable | $13M | $14M | $12M | $9M | $7M | $7M | |
| Accrued Liabilities | $116M | $67M | $34M | $28M | $26M | $15M | |
| Current Liabilities | $130M | $81M | $47M | $38M | $33M | $23M | |
| Capital Leases | $5M | $3M | $3M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $431.0K | $570.0K | $849.0K | $0 | $25.0K | $82.0K | |
| Total Liabilities | $243M | $191M | $253M | $240M | $110M | $28M | |
| Long-term Debt | $109M | $107M | $202M | $198M | $72M | $0 | |
| Total Debt | $109M | $107M | $202M | · | · | · | |
| Common Stock | $12.0K | $12.0K | $9.0K | $6.0K | $5.0K | $4.0K | |
| Paid-in Capital | $1.33B | $1.28B | $1.07B | $930M | $706M | $473M | |
| Retained Earnings | $-1.14B | $-1.12B | $-982M | $-720M | $-408M | $-202M | |
| AOCI | $-44.0K | $-7.0K | $4.0K | $-1M | $-255.0K | $-2.0K | |
| Stockholders' Equity | $189M | $158M | $89M | $210M | $298M | $271M | |
| Liabilities + Equity | $433M | $349M | $341M | $449M | $408M | $298M | |
| Shares Outstanding | 123,333,000 | 117,848,033 | 96,787,343 | 61,037,403 | 50,255,614 | 43,338,438 |
Flujo de Efectivo 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $42M | $39M | $33M | $24M | $8M | |
| Deferred Tax | $54.0K | $-152.0K | $0 | $0 | $0 | · | |
| Amort. of Intangibles | $5M | $2M | $750.0K | $312.0K | $0 | $0 | |
| Operating Cash Flow | $-6M | $-112M | $-247M | $-258M | $-175M | $-113M | |
| CapEx | $686.0K | $143.0K | $428.0K | $333.0K | $995.0K | $321.0K | |
| Investing Cash Flow | $-30M | $29M | $180M | $-87M | $-76M | $-182M | |
| Debt Issued | · | $0 | $0 | $125M | $74M | $0 | |
| Net Debt Issued | $0 | $-100M | $0 | · | · | · | |
| Stock Issued | $0 | $162M | $0 | $162M | $207M | $128M | |
| Net Stock Activity | $0 | $162M | $0 | · | · | $128M | |
| Financing Cash Flow | $7M | $66M | $101M | $302M | $282M | $298M | |
| Net Change in Cash | $-29M | $-17M | $34M | $-43M | $31M | $3M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | |
| Free Cash Flow | $-6M | $-112M | $-247M | · | · | $-113M |
Rentabilidad 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| Net Margin | -4.3% | -71.2% | -439.8% | · | · | · | |
| EBITDA Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| ROA | -4.1% | -40.6% | -66.3% | · | · | -67.0% | |
| ROE | -9.8% | -89.1% | -387.2% | · | · | -61.2% |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 4.1 | 7.1 | · | · | 13.0 | |
| Quick Ratio | 1.5 | 1.8 | 2.4 | · | · | 2.9 | |
| Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| Interest Coverage | · | · | -8.1 | · | · | · |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.2 | · | · | · | |
| Inventory Turnover | 2.0 | 1.4 | 0.5 | · | · | · | |
| Receivables Turnover | 3.4 | 4.0 | 3.5 | · | · | · |
Tasas de Crecimiento 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 91.3% | 229.7% | 1517.1% | · | · | · | |
| Revenue CAGR 3Y | 367.3% | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $376M | $197M | $60M | $4M | $0 | $0 | |
| Net Income TTM | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| Market Cap | $3.58B | $1.64B | $313M | · | · | $1.22B | |
| Enterprise Value | $3.65B | $1.68B | $426M | · | · | · | |
| P/E | -223.4 | -12.0 | -0.9 | -2.6 | -5.0 | -7.4 | |
| P/S | 9.5 | 8.4 | 5.2 | · | · | · | |
| P/B | 18.9 | 10.4 | 3.5 | · | · | 4.5 | |
| P / Tangible Book | 20.5 | 11.1 | 3.8 | 4.5 | 3.5 | 4.5 | |
| P / Cash Flow | -636.7 | -14.6 | -1.3 | · | · | -10.8 | |
| P / FCF | -567.5 | -14.6 | -1.3 | · | · | -10.8 | |
| EV / EBITDA | -298.3 | -13.1 | -1.8 | · | · | · | |
| EV / FCF | -578.0 | -14.9 | -1.7 | · | · | · | |
| EV / Revenue | 9.7 | 8.5 | 7.1 | · | · | · | |
| Earnings Yield | -0.45% | -8.3% | -117.0% | -38.2% | -20.2% | -13.5% |
Estado de resultados 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130M | $105M | $130M | $99M | $82M | $66M | $71M | $45M | $31M | $50M | $14M | $38M | $5M | $3M | $3M | $725.0K | |
| Cost of Revenue | $11M | $10M | $12M | $9M | $7M | $9M | $7M | $6M | $3M | $3M | $2M | $1M | $776.0K | $783.0K | · | · | |
| R&D Expense | $20M | $31M | $20M | $20M | $19M | $18M | $14M | $20M | $19M | $23M | $24M | $26M | $25M | $35M | $34M | $70M | |
| SG&A Expense | $82M | $74M | $79M | $62M | $69M | $64M | $58M | $59M | $58M | $55M | $49M | $48M | $46M | $43M | $37M | $35M | |
| Operating Expenses | $113M | $114M | $111M | $91M | $96M | $90M | $79M | $84M | $81M | $81M | $75M | $75M | $72M | $79M | $71M | $105M | |
| Operating Income | $16M | $-9M | $18M | $9M | $-15M | $-25M | $-8M | $-39M | $-50M | $-32M | $-61M | $-37M | $-67M | $-76M | $-68M | $-105M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $8M | $7M | $7M | · | $5M | |
| Interest Income | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-157.0K | $-20.0K | $-6M | $2M | $20.0K | $193.0K | $-13M | $4M | $5M | $4M | $-10M | $3M | $3M | $3M | $3M | $2M | |
| Income Tax | $136.0K | $93.0K | $470.0K | $80.0K | $342.0K | $279.0K | $323.0K | $0 | $0 | $324.0K | $90.0K | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $15M | $-11M | $17M | $7M | $-16M | $-25M | $-11M | $-42M | $-52M | $-35M | $-66M | $-45M | $-71M | $-80M | $-72M | $-108M | |
| EPS (Basic) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| EPS (Diluted) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| Shares (Basic) | 130,522,000 | 129,365 | -253,422,862 | 127,623,000 | 126,997,000 | 126,037 | -237,873,525 | 124,302,000 | 123,481,000 | 111,048,525 | -115,021,987 | 61,727,278 | 61,430,620 | 61,169,089 | -103,995,388 | 57,091,743 | |
| Shares (Diluted) | 135,898,000 | 129,365 | -258,684,862 | 132,885,000 | 126,997,000 | 126,037 | -237,873,525 | 124,302,000 | 123,481,000 | 111,048,525 | -115,021,987 | 61,727,278 | 61,430,620 | 61,169,089 | -103,995,388 | 57,091,743 | |
| EBITDA | $16M | $-9M | · | $9M | $-15M | $-25M | · | $-39M | $-50M | · | · | $-37M | · | · | · | $-105M |
Balance general 26
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $35M | $43M | $47M | $73M | $53M | $71M | $135M | $84M | $190M | · | $107M | $105M | $81M | · | $82M | |
| Receivables | $155M | $144M | $146M | $115M | $107M | $85M | $73M | $60M | $43M | $37M | · | $19M | $17M | $13M | · | $2M | |
| Inventory | $39M | $37M | $23M | $22M | $16M | $17M | $15M | $14M | $14M | $13M | · | $14M | $10M | $9M | · | $4M | |
| Prepaid Expense | $35M | $32M | $21M | $20M | $19M | $23M | $20M | $18M | $14M | $13M | · | $20M | $12M | $13M | · | $12M | |
| Current Assets | $468M | $438M | $411M | $349M | $333M | $324M | $336M | $424M | $435M | $468M | · | $282M | $309M | $368M | · | $497M | |
| PP&E (Net) | $872.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | · | · | $2M | $2M | $1M | · | $993.0K | |
| Intangibles | $14M | $14M | $15M | $15M | $16M | $16M | $9M | $10M | $6M | $6M | · | $7M | $7M | $7M | · | $7M | |
| Other Non-current Assets | $2M | $2M | $1M | $596.0K | $596.0K | $596.0K | $596.0K | $596.0K | $595.0K | $596.0K | · | $596.0K | $596.0K | $78.0K | · | $78.0K | |
| Total Assets | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Accounts Payable | $7M | $18M | $13M | $6M | $15M | $25M | $14M | $19M | $8M | $13M | · | $13M | $17M | $12M | · | $9M | |
| Accrued Liabilities | $147M | $137M | $116M | $93M | $88M | $66M | $67M | $53M | $43M | $34M | · | $28M | $19M | $24M | · | $28M | |
| Current Liabilities | $160M | $163M | $130M | $100M | $104M | $91M | $81M | $172M | $51M | $47M | · | $42M | $37M | $37M | · | $37M | |
| Capital Leases | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-current Liabilities | $431.0K | $431.0K | $431.0K | $360.0K | $360.0K | $360.0K | $570.0K | $420.0K | $194.0K | $306.0K | · | · | · | · | · | $0 | |
| Total Liabilities | $268M | $270M | $243M | $213M | $213M | $201M | $191M | $281M | $258M | $254M | · | $246M | $240M | $240M | · | $238M | |
| Long-term Debt | $109M | $109M | $109M | $108M | $108M | $108M | $107M | $205M | $204M | $203M | · | $201M | $200M | $199M | · | $197M | |
| Total Debt | $109M | $109M | · | $108M | $108M | $108M | · | $205M | $204M | · | · | $201M | · | · | · | $197M | |
| Common Stock | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $1.36B | $1.34B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.27B | $1.26B | $1.24B | · | $963M | $952M | $940M | · | $920M | |
| Retained Earnings | $-1.13B | $-1.15B | $-1.14B | $-1.16B | $-1.16B | $-1.15B | $-1.12B | $-1.11B | $-1.07B | $-1.02B | · | $-916M | $-871M | $-800M | · | $-648M | |
| AOCI | $-656.0K | $-514.0K | $-44.0K | $-62.0K | $-35.0K | $-140.0K | $-7.0K | $533.0K | $-294.0K | $-133.0K | · | $-184.0K | $-292.0K | $-414.0K | · | $-2M | |
| Stockholders' Equity | $221M | $190M | $189M | $158M | $139M | $143M | $158M | $157M | $186M | $225M | $89M | $47M | $81M | $140M | $210M | $271M | |
| Liabilities + Equity | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Shares Outstanding | 125,591,000 | 125,042,000 | 123,332,672 | 120,288,146 | 119,797,738 | 119,137,785 | 117,848,033 | 116,998,829 | 116,480,267 | 115,505,437 | · | 61,858,044 | 61,630,018 | 61,357,932 | · | 60,908,641 |
Flujo de Efectivo 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $11M | $10M | $10M | $10M | $10M | $9M | $10M | $13M | $10M | $9M | $10M | $11M | $9M | $9M | $9M | |
| Amort. of Intangibles | $563.0K | $562.0K | $563.0K | $562.0K | $563.0K | $3M | $313.0K | $1M | $200.0K | $188.0K | $-188M | $188M | $200.0K | $188.0K | $187.0K | $125.0K | |
| Operating Cash Flow | $13M | $2M | $26M | $-2M | $324.0K | $-30M | $-748.0K | $-35M | $-45M | $-32M | $-56M | $-44M | $-66M | $-80M | $-71M | $-68M | |
| CapEx | $158.0K | $0 | $0 | $0 | $78.0K | $608.0K | $0 | $143.0K | $0 | $0 | $6.0K | $64.0K | $276.0K | $82.0K | $123.0K | $6.0K | |
| Investing Cash Flow | $-15M | $-11M | $-34M | $-25M | $17M | $12M | $35M | $85M | $-62M | $-29M | $-62M | $46M | $89M | $108M | $42M | $-197M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $162M | $0 | $0 | $0 | $0 | $0 | $162M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $1M | $4M | $1M | $1M | $395.0K | $-97M | $394.0K | $1M | $162M | $99M | $867.0K | $1M | $100.0K | $962.0K | $285M | |
| Net Change in Cash | $-641.0K | $-8M | $-4M | $-26M | $19M | $-18M | $-64M | $51M | $-106M | $101M | $-19M | $2M | $24M | $27M | $-28M | $20M | |
| Free Cash Flow | · | $2M | · | · | · | $-31M | · | · | · | · | · | · | · | · | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| Net Margin | 11.6% | -10.7% | · | 7.5% | -19.5% | -38.1% | · | -92.8% | -169.6% | · | · | -117.5% | · | · | · | -14856.4% | |
| EBITDA Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| ROA | 3.6% | -2.8% | · | 1.8% | -4.0% | -6.1% | · | -11.4% | -13.7% | · | · | -11.2% | · | · | · | -24.0% | |
| ROE | 8.3% | -6.8% | · | 4.7% | -9.8% | -13.6% | · | -40.8% | -39.2% | · | · | -28.2% | · | · | · | -34.0% |
Liquidez y Solvencia 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.7 | · | 3.5 | 3.2 | 3.6 | · | 2.5 | 8.5 | · | · | 6.7 | · | · | · | 13.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.6 | 1.7 | 1.5 | · | 1.1 | 2.5 | · | · | 3.0 | · | · | · | 2.3 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 1.3 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -21.4 |
Eficiencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | · | · | 0.1 | · | · | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.4 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.0 | 0.9 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.0 | · | · | 3.5 | · | · | · | 0.6 |
Valoración (TTM) 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $416M | $352M | · | $291M | $223M | $191M | · | $163M | $124M | $96M | · | $47M | $9M | $4M | · | $725.0K | |
| Net Income TTM | $-5M | $-45M | · | $-75M | $-135M | $-154M | · | $-174M | $-203M | $-231M | · | $-304M | $-326M | $-320M | · | $-296M | |
| Market Cap | $3.29B | $2.95B | · | $2.27B | $1.68B | $1.86B | · | $1.09B | $1.08B | · | · | $328M | · | · | · | $1.16B | |
| Enterprise Value | $3.37B | $3.02B | · | $2.33B | $1.71B | $1.92B | · | $1.16B | $1.20B | · | · | $422M | · | · | · | $1.28B | |
| P/E | -524.4 | -65.4 | · | -31.4 | -13.0 | -12.3 | · | -5.2 | -3.5 | -2.8 | · | -1.0 | -1.7 | -1.9 | · | -3.4 | |
| P/S | 7.9 | 8.4 | · | 7.8 | 7.5 | 9.8 | · | 6.7 | 8.8 | · | · | 7.0 | · | · | · | 1605.5 | |
| P/B | 14.9 | 15.5 | · | 14.3 | 12.1 | 13.1 | · | 6.9 | 5.8 | · | · | 7.0 | · | · | · | 4.3 | |
| P / Tangible Book | 15.9 | 16.8 | · | 15.9 | 13.7 | 14.8 | · | 7.4 | 6.0 | 5.2 | · | 8.2 | 8.0 | 5.1 | · | 4.4 | |
| P / Cash Flow | · | 1315.8 | · | · | · | -61.3 | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | · | 1315.8 | · | · | · | -60.1 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 205.0 | -332.3 | · | 273.1 | -117.4 | -78.2 | · | -29.6 | -24.0 | · | · | -11.4 | · | · | · | -12.2 | |
| EV / FCF | · | 1349.1 | · | · | · | -61.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 8.1 | 8.6 | · | 8.0 | 7.7 | 10.0 | · | 7.1 | 9.7 | · | · | 9.0 | · | · | · | 1764.4 | |
| Earnings Yield | -0.19% | -1.5% | · | -3.2% | -7.7% | -8.1% | · | -19.4% | -28.3% | -35.5% | · | -95.9% | -59.5% | -52.5% | · | -29.4% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $376M | $197M | $60M | $4M | $0 |
| Margen Operativo % | -3.2% | -65.3% | -404.5% | — | — |
| Beneficio neto | $-16M | $-140M | $-262M | $-311M | $-206M |
| EPS Diluido | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.6 | 0.7 | 2.3 | — | — |
| Ratio corriente | 3.2 | 4.1 | 7.1 | — | — |
| Ratio Rápido | 1.5 | 1.8 | 2.4 | — | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-6M | $-112M | $-247M | — | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 293 declarantes · $2.6B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 47 (+5 vs trimestre anterior) | 33 (-8 vs trimestre anterior) | 90 (-10 vs trimestre anterior) | 96 (+4 vs trimestre anterior) | -1.8M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $326 098 140 | 12 437 000 | 12,34% | Acciones |
| Frazier Life Sciences Management, L.P. | $258 909 678 | 9 874 511 | 9,80% | Acciones |
| Rubric Capital Management LP | $216 880 749 | 8 271 577 | 8,21% | Acciones |
| Polar Capital Holdings Plc | $173 234 098 | 6 606 945 | 6,56% | Acciones |
| STATE STREET CORP | $152 674 865 | 5 822 840 | 5,78% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $130 805 182 | 4 988 756 | 4,95% | Acciones |
| JENNISON ASSOCIATES LLC | $86 505 943 | 3 299 235 | 3,27% | Acciones |
| D. E. Shaw & Co., Inc. | $81 220 383 | 3 097 650 | 3,07% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $67 179 379 | 2 561 595 | 2,54% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $63 688 511 | 2 429 005 | 2,41% | Acciones |
| ORBIMED ADVISORS LLC | $53 541 240 | 2 042 000 | 2,03% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $50 474 363 | 1 925 031 | 1,91% | Acciones |
| JANUS HENDERSON GROUP PLC | $42 621 972 | 1 809 466 | 1,61% | Acciones |
| OBERWEIS ASSET MANAGEMENT INC/ | $35 998 513 | 1 372 941 | 1,36% | Acciones |
| GILDER GAGNON HOWE & CO LLC | $34 432 392 | 1 313 211 | 1,30% | Acciones |
| Pivotal bioVenture Partners Investment Advisor LLC | $33 175 720 | 1 265 283 | 1,26% | Acciones |
| BANK OF AMERICA CORP /DE/ | $33 121 130 | 1 263 201 | 1,25% | Acciones |
| BAMCO INC /NY/ | $32 856 806 | 1 253 120 | 1,24% | Acciones |
| CITADEL ADVISORS LLC | $29 766 543 | 1 135 261 | 1,13% | Acciones |
| Aberdeen Group plc | $28 635 465 | 1 092 123 | 1,08% | Acciones |
| Jones Hill Capital LP | $28 571 960 | 1 089 701 | 1,08% | Acciones |
| GOLDMAN SACHS GROUP INC | $28 558 011 | 1 089 169 | 1,08% | Acciones |
| Perpetual Ltd | $27 642 802 | 1 054 264 | 1,05% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $27 555 489 | 1 050 934 | 1,04% | Acciones |
| Ensign Peak Advisors, Inc | $25 552 281 | 974 534 | 0,97% | Acciones |
| Candriam S.C.A. | $24 880 817 | 949 839 | 0,94% | Acciones |
| Driehaus Capital Management LLC | $23 032 330 | 878 426 | 0,87% | Acciones |
| VANGUARD GROUP INC | $22 159 001 | 763 051 | 0,84% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $21 372 918 | 815 138 | 0,81% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21 284 137 | 811 752 | 0,81% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $17 406 855 | 663 877 | 0,66% | Acciones |
| FISHMAN JAY A LTD/MI | $15 601 031 | 595 005 | 0,59% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $14 789 968 | 564 072 | 0,56% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $14 349 629 | 547 278 | 0,54% | Acciones |
| Squarepoint Ops LLC | $14 099 726 | 537 747 | 0,53% | Acciones |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $13 110 000 | 500 000 | 0,50% | Acciones |
| Nearwater Capital Markets, Ltd | $12 761 274 | 486 700 | 0,48% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12 218 520 | 466 000 | 0,46% | Acciones |
| Privium Fund Management B.V. | $10 471 403 | 399 367 | 0,40% | Acciones |
| NORGES BANK | $10 286 106 | 392 300 | 0,39% | Acciones |
| Patient Square Capital LP | $9 701 400 | 370 000 | 0,37% | Acciones |
| Point72 Asset Management, L.P. | $9 503 413 | 362 449 | 0,36% | Acciones |
| Qube Research & Technologies Ltd | $9 482 778 | 361 662 | 0,36% | Acciones |
| Longaeva Partners L.P. | $9 040 551 | 344 796 | 0,34% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8 741 748 | 333 400 | 0,33% | Opción de compra |
| FMR LLC | $8 001 453 | 305 166 | 0,30% | Acciones |
| PEREGRINE CAPITAL MANAGEMENT LLC | $7 641 740 | 291 447 | 0,29% | Acciones |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $7 467 168 | 284 789 | 0,28% | Acciones |
| FIRST TRUST ADVISORS LP | $7 448 184 | 284 065 | 0,28% | Acciones |
| AMERIPRISE FINANCIAL INC | $7 133 676 | 272 070 | 0,27% | Acciones |
| Walleye Capital LLC | $6 818 065 | 260 033 | 0,26% | Acciones |
| Balyasny Asset Management L.P. | $6 374 580 | 243 119 | 0,24% | Acciones |
| PFM Health Sciences, LP | $6 347 049 | 242 069 | 0,24% | Acciones |
| MYDA Advisors LLC | $6 292 800 | 240 000 | 0,24% | Acciones |
| STATE OF WISCONSIN INVESTMENT BOARD | $6 054 329 | 230 905 | 0,23% | Acciones |
| Swiss National Bank | $5 873 280 | 224 000 | 0,22% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5 763 549 | 219 815 | 0,22% | Acciones |
| Pictet Asset Management Holding SA | $5 350 188 | 200 275 | 0,20% | Acciones |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $5 235 688 | 199 683 | 0,20% | Acciones |
| Woodline Partners LP | $5 113 765 | 195 033 | 0,19% | Acciones |
| BlackRock, Inc. | $4 724 084 | 180 171 | 0,18% | Acciones |
| Cormorant Asset Management, LP | $4 588 500 | 175 000 | 0,17% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $4 586 166 | 174 911 | 0,17% | Acciones |
| TWO SIGMA ADVISERS, LP | $4 533 144 | 156 100 | 0,17% | Acciones |
| RHUMBLINE ADVISERS | $4 471 596 | 170 542 | 0,17% | Acciones |
| Holocene Advisors, LP | $4 293 053 | 163 732 | 0,16% | Acciones |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $4 127 788 | 157 429 | 0,16% | Acciones |
| PDT Partners, LLC | $4 066 067 | 155 075 | 0,15% | Acciones |
| CITIGROUP INC | $3 796 394 | 144 790 | 0,14% | Acciones |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $3 616 499 | 137 929 | 0,14% | Acciones |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $3 605 250 | 137 500 | 0,14% | Acciones |
| CASTLEARK MANAGEMENT LLC | $3 603 152 | 137 420 | 0,14% | Acciones |
| Eversept Partners, LP | $3 549 008 | 135 355 | 0,13% | Acciones |
| LAZARD ASSET MANAGEMENT LLC | $3 491 088 | 133 146 | 0,13% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $3 458 785 | 131 914 | 0,13% | Acciones |
| MORGAN STANLEY | $3 424 175 | 130 594 | 0,13% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $3 213 419 | 136 393 | 0,12% | Acciones |
| JANE STREET GROUP, LLC | $3 088 716 | 117 800 | 0,12% | Opción de compra |
| 1492 Capital Management LLC | $3 047 052 | 116 211 | 0,12% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3 023 149 | 128 317 | 0,11% | Acciones |
| Tejara Capital Ltd | $2 965 062 | 113 084 | 0,11% | Acciones |
| LPL Financial LLC | $2 914 353 | 111 150 | 0,11% | Acciones |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2 776 671 | 103 762 | 0,11% | Acciones |
| STEMPOINT CAPITAL LP | $2 594 338 | 98 945 | 0,10% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2 496 000 | 95 197 | 0,09% | Acciones |
| CITADEL ADVISORS LLC | $2 480 412 | 94 600 | 0,09% | Opción de compra |
| Aquatic Capital Management LLC | $2 258 329 | 86 130 | 0,09% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2 255 628 | 86 027 | 0,09% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $2 135 488 | 81 445 | 0,08% | Acciones |
| WESBANCO BANK INC | $2 126 442 | 81 100 | 0,08% | Acciones |
| Rafferty Asset Management, LLC | $2 117 973 | 80 777 | 0,08% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $1 981 498 | 75 572 | 0,08% | Acciones |
| JUPITER ASSET MANAGEMENT LTD | $1 980 685 | 75 541 | 0,07% | Acciones |
| Erste Asset Management GmbH | $1 956 156 | 73 100 | 0,07% | Acciones |
| FEDERATED HERMES, INC. | $1 952 315 | 74 459 | 0,07% | Acciones |
| Jain Global LLC | $1 917 757 | 73 141 | 0,07% | Acciones |
| Vontobel Holding Ltd. | $1 789 305 | 68 242 | 0,07% | Acciones |
| MetLife Investment Management, LLC | $1 747 012 | 66 629 | 0,07% | Acciones |
| Focus Partners Wealth | $1 651 363 | 62 981 | 0,06% | Acciones |
| CenterBook Partners LP | $1 597 925 | 60 943 | 0,06% | Acciones |
Informantes de la empresa 18 insiders · 2 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Scott L Burrows | Chief Financial Officer | 27 de diciembre de 2021 S | 22 679 | 0 | 0 | $0 |
| David W Osborne | Chief Technical Officer | 4 de febrero de 2020 C | 270 279 | 0 | 0 | $0 |
| Howard G. Welgus | Consejero | 15 de julio de 2026 M | 37 109 | 0 | 3 | $-243 567 |
| Christopher Peetz | Consejero | 15 de julio de 2026 A | 4 315 | 0 | 0 | $0 |
| Sue-Jean Lin | Consejero | 15 de junio de 2026 S | 27 567 | 0 | 1 | $-120 583 |
| Neha Krishnamohan | Consejero | 5 de junio de 2026 A | 27 901 | 0 | 0 | $0 |
| Terrie Curran | Consejero | 5 de junio de 2026 A | 23 526 | 0 | 0 | $0 |
| Amit Munshi | Consejero | 5 de junio de 2026 A | 9 799 | 0 | 0 | $0 |
| Halley E Gilbert | Consejero | 5 de junio de 2026 A | 27 901 | 0 | 0 | $0 |
| Keith R Leonard | Consejero | 5 de junio de 2026 A | 27 901 | 0 | 0 | $0 |
| Patrick J. Heron | Consejero | 5 de junio de 2026 A | 32 213 | 0 | 0 | $0 |
| Jonathan Silverstein | Consejero | 2 de octubre de 2020 P | 902 286 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Consejero | 4 de febrero de 2020 C | 49 981 | 0 | 0 | $0 |
| Joseph L Turner | Consejero | 30 de enero de 2020 A | — | 0 | 0 | $0 |
| Patrick Burnett | — | 12 de agosto de 2026 M | 119 289 | 0 | 3 | $-419 797 |
| Todd Franklin Watanabe | — | 3 de agosto de 2026 S | 717 203 | 0 | 1 | $-114 275 |
| Masaru Matsuda | — | 3 de agosto de 2026 S | 126 171 | 0 | 1 | $-32 128 |
| Ricky Sun | — | 9 de junio de 2021 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P., FHM LIFE SCIENCES VIII, L.P., FHM LIFE SCIENCES VIII, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×8 presentaciones | 20 de agosto de 2025 | 7,50% | Enmienda | Inversión pasiva | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital LLC ×7 presentaciones | 26 de agosto de 2022 | — | Presentación inicial | — | SEC |
| Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP ×4 presentaciones | 8 de agosto de 2022 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 46 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,28% | 32 610 NS | 30 de abril de 2026 | N-PORT |
| GURU · Global X Funds | 0,95% | 23 918 NS | 30 de abril de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,88% | 196 991 NS | 30 de abril de 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,54% | 70 043 NS | 31 de mayo de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,32% | 145 888 NS | 30 de abril de 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,20% | 9 018 NS | 31 de mayo de 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,19% | 172 935 NS | 30 de junio de 2026 | N-PORT |
| OASC · Unified Series Trust | 0,17% | 6 744 NS | 31 de mayo de 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,17% | 88 401 NS | 30 de abril de 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,16% | 74 441 NS | 31 de mayo de 2026 | N-PORT |
| BIB · ProShares Trust | 0,13% | 4 587 NS | 31 de mayo de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 41 766 NS | 30 de abril de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,11% | 3 711 NS | 30 de abril de 2026 | N-PORT |
| RSSL · Global X Funds | 0,08% | 47 709 NS | 30 de abril de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 13 604 NS | 30 de abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 5 179 NS | 31 de mayo de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 534 058 NS | 31 de mayo de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 50 560 NS | 30 de abril de 2026 | N-PORT |
| UWM · ProShares Trust | 0,03% | 4 051 NS | 31 de mayo de 2026 | N-PORT |
| URTY · ProShares Trust | 0,03% | 4 104 NS | 31 de mayo de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 4 427 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 103 NS | 31 de mayo de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 33 557 NS | 31 de mayo de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 3 054 NS | 30 de abril de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 64 126 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 de julio de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| ITOT · iShares Trust | — | — | 5 de agosto de 2026 | Diario |
| IWV · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWO · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWM · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IBB · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| PTH · Invesco Exchange-Traded Fund Trust | — | — | 13 de julio de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 de julio de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 de julio de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | — | — | 20 de julio de 2026 | Diario |
| ISCB · iShares Trust | — | — | 5 de agosto de 2026 | Diario |
| ISCG · iShares Trust | — | — | 5 de agosto de 2026 | Diario |
| ESML · iShares Trust | — | — | 14 de agosto de 2026 | Diario |
| WSML · iShares Trust | — | — | 5 de agosto de 2026 | Diario |
| DWAS · Invesco Exchange-Traded Fund Trust … | — | — | 20 de julio de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 de julio de 2026 | Diario |